Publications

June 9, 2022

EHA – 2022 – Poster Presentation 1429

Platform, VOR33-CLL1 + VCAR33-CLL1 Treatment System

Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment